Matches in SemOpenAlex for { <https://semopenalex.org/work/W2891874109> ?p ?o ?g. }
- W2891874109 endingPage "1030" @default.
- W2891874109 startingPage "999" @default.
- W2891874109 abstract "Most direct-acting antivirals (DAAs) and psychotropic drugs are metabolized by or induct/inhibit CYP enzymes and drug transporters. Although they are frequently coadministered, the drug-drug interactions (DDIs) have been little studied. Therefore, the aim of this review is to describe the interactions between the approved DAA or combination regimens and the main psychoactive substances, including legal and illegal drugs of abuse. Areas covered: We performed a literature search on PubMed database on drug interactions with the currently available antivirals for hepatitis C and a review of the information on pharmacokinetics, metabolism, and drug interactions from www.hep-druginteractions.org and from all the Summary of Product Characteristics (SmPC). This review covers the DDI between the DAA regimens approved, such as simeprevir and sofosbuvir, paritaprevir, glecaprevir, voxilaprevir, ombitasvir, ledipasvir, daclatasvir and sofosbuvir, elbasvir and grazoprevir, sofosbuvir and velpatasvir, glecaprevir/pibrentasvir, sofosbuvir and velpatasvir, and main psychotropic agents. Expert Commentary: DAA regimens based on sofosbuvir combination usually have less DDI than protease inhibitor-based regimens. Among protease inhibitors regimens, new combinations, such as glecaprevir/elbasvir and grazoprevir/elbasvir, seemed to have less DDI than the combination POrD (paritaprevir/ombitasvir/ritonavir/dasabuvir). However, the analysis of each interaction is theoretical and further interaction studies would be necessary to confirm actual effect." @default.
- W2891874109 created "2018-09-27" @default.
- W2891874109 creator A5015257963 @default.
- W2891874109 creator A5033344017 @default.
- W2891874109 creator A5063092297 @default.
- W2891874109 creator A5079557826 @default.
- W2891874109 date "2018-09-29" @default.
- W2891874109 modified "2023-10-01" @default.
- W2891874109 title "The pharmacological interactions between direct-acting antivirals for the treatment of chronic hepatitis c and psychotropic drugs" @default.
- W2891874109 cites W1841839642 @default.
- W2891874109 cites W1881009043 @default.
- W2891874109 cites W1949754879 @default.
- W2891874109 cites W1977312622 @default.
- W2891874109 cites W2005697115 @default.
- W2891874109 cites W2038764499 @default.
- W2891874109 cites W2040117569 @default.
- W2891874109 cites W2042367007 @default.
- W2891874109 cites W2051633925 @default.
- W2891874109 cites W2072765173 @default.
- W2891874109 cites W2099832389 @default.
- W2891874109 cites W2104563699 @default.
- W2891874109 cites W2113573607 @default.
- W2891874109 cites W2129210624 @default.
- W2891874109 cites W2153538902 @default.
- W2891874109 cites W2156165455 @default.
- W2891874109 cites W2164172064 @default.
- W2891874109 cites W2173594456 @default.
- W2891874109 cites W2185218296 @default.
- W2891874109 cites W2202569540 @default.
- W2891874109 cites W2345528964 @default.
- W2891874109 cites W2432185009 @default.
- W2891874109 cites W2443680666 @default.
- W2891874109 cites W2517964493 @default.
- W2891874109 cites W2553101543 @default.
- W2891874109 cites W2589802992 @default.
- W2891874109 cites W2592128079 @default.
- W2891874109 cites W2592428844 @default.
- W2891874109 cites W2594517528 @default.
- W2891874109 cites W2605753778 @default.
- W2891874109 cites W2606367608 @default.
- W2891874109 cites W2606965977 @default.
- W2891874109 cites W2762789262 @default.
- W2891874109 cites W2773476353 @default.
- W2891874109 cites W2779091025 @default.
- W2891874109 cites W654975578 @default.
- W2891874109 cites W2593556555 @default.
- W2891874109 doi "https://doi.org/10.1080/17512433.2018.1519392" @default.
- W2891874109 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/30199279" @default.
- W2891874109 hasPublicationYear "2018" @default.
- W2891874109 type Work @default.
- W2891874109 sameAs 2891874109 @default.
- W2891874109 citedByCount "19" @default.
- W2891874109 countsByYear W28918741092019 @default.
- W2891874109 countsByYear W28918741092020 @default.
- W2891874109 countsByYear W28918741092021 @default.
- W2891874109 countsByYear W28918741092022 @default.
- W2891874109 countsByYear W28918741092023 @default.
- W2891874109 crossrefType "journal-article" @default.
- W2891874109 hasAuthorship W2891874109A5015257963 @default.
- W2891874109 hasAuthorship W2891874109A5033344017 @default.
- W2891874109 hasAuthorship W2891874109A5063092297 @default.
- W2891874109 hasAuthorship W2891874109A5079557826 @default.
- W2891874109 hasConcept C142462285 @default.
- W2891874109 hasConcept C159047783 @default.
- W2891874109 hasConcept C2522874641 @default.
- W2891874109 hasConcept C2775999097 @default.
- W2891874109 hasConcept C2776408679 @default.
- W2891874109 hasConcept C2776979040 @default.
- W2891874109 hasConcept C2777100407 @default.
- W2891874109 hasConcept C2778390639 @default.
- W2891874109 hasConcept C2778785139 @default.
- W2891874109 hasConcept C2778867932 @default.
- W2891874109 hasConcept C2778986448 @default.
- W2891874109 hasConcept C2779298103 @default.
- W2891874109 hasConcept C2780035454 @default.
- W2891874109 hasConcept C2780040827 @default.
- W2891874109 hasConcept C2993143319 @default.
- W2891874109 hasConcept C3013748606 @default.
- W2891874109 hasConcept C71924100 @default.
- W2891874109 hasConcept C97320921 @default.
- W2891874109 hasConcept C98274493 @default.
- W2891874109 hasConceptScore W2891874109C142462285 @default.
- W2891874109 hasConceptScore W2891874109C159047783 @default.
- W2891874109 hasConceptScore W2891874109C2522874641 @default.
- W2891874109 hasConceptScore W2891874109C2775999097 @default.
- W2891874109 hasConceptScore W2891874109C2776408679 @default.
- W2891874109 hasConceptScore W2891874109C2776979040 @default.
- W2891874109 hasConceptScore W2891874109C2777100407 @default.
- W2891874109 hasConceptScore W2891874109C2778390639 @default.
- W2891874109 hasConceptScore W2891874109C2778785139 @default.
- W2891874109 hasConceptScore W2891874109C2778867932 @default.
- W2891874109 hasConceptScore W2891874109C2778986448 @default.
- W2891874109 hasConceptScore W2891874109C2779298103 @default.
- W2891874109 hasConceptScore W2891874109C2780035454 @default.
- W2891874109 hasConceptScore W2891874109C2780040827 @default.
- W2891874109 hasConceptScore W2891874109C2993143319 @default.
- W2891874109 hasConceptScore W2891874109C3013748606 @default.
- W2891874109 hasConceptScore W2891874109C71924100 @default.